News

Stay up to date with our products and technology by reading the most recent news articles.
CincyInno: Cincinnati startup lands multimillion dollar military contract

CincyInno: Cincinnati startup lands multimillion dollar military contract

Sense Neuro Diagnostics, founded in 2014 by four University of Cincinnati physicians, said the $2.43 million, 18-month award from the U.S. Department of Defense will accelerate development of a new rapid, noninvasive brain scanner that can detect and continuously monitor traumatic brain injury in a battlefield or field environment.

CincyInno: No longer heads down: This Cincinnati startup is starting to make waves

CincyInno: No longer heads down: This Cincinnati startup is starting to make waves

"The fact that we can differentiate between all three stroke subtypes makes us stronger than our competition," Sense Neuro Diagnostics CEO Geoff Klass recently told reporter Liz Engel of CincyInno. "We feel very comfortable with our position. When it comes to in-hospital monitoring, we’re the only company developing a product to handle that."

Sense Diagnostics inks 'know-how' license agreement with Mayo Clinic

Cincinnati Business Courier
December 14, 2022

MedCity INVEST Pitch Perfect Winners

National Healthcare
Investing Event
July 20-24 2020. Virtual Conference.

This Device Looks Inside Your Brain

Cincinnati Public Radio
Jun 19, 2017

The Sensor Evaluation of Neurologic Status in Emergencies (SENSE) Device

American College of Emergency Physicians
May 2017

2017 Health Care Heroes finalist: Dr. Opeolu Adeoye

Cincinnati Business Courier
Feb 23, 2017

Accelerant funds two start-ups up to $250K each

Dayton Daily News
Feb 09, 2017

In a hospital, he’s a mind reader

University of Cincinnati College of Medicine

May, 2016

Cincinnati Health Briefs for April 27

Cincinnati.com
Apr 26, 2016

Certain statements in this release are forward-looking and subject to risks and uncertainties. Actual results may differ materially depending on regulatory review, funding, and other factors.

Copyright Sense Neuro. 2026. All Rights Reserved. Designed by Node

NeuroHawk™ is an investigational device and is not yet cleared or approved by the U.S. Food and Drug Administration (FDA). It is not available for sale or clinical use in the United States. Information provided is for educational and investor purposes only.